Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Cardiovascular Diabetology
IF
5.24
Papers
1664
Papers 1691
1 page of 170 pages (1,691 results)
Newest
Published on Mar 11, 2019in Cardiovascular Diabetology 5.24
Guillaume Besch4
Estimated H-index: 4
(UFC: University of Franche-Comté),
S. Pili-Floury10
Estimated H-index: 10
(UFC: University of Franche-Comté)
+ 10 AuthorsFrancois Schiele37
Estimated H-index: 37
(UFC: University of Franche-Comté)
Background Glycemic variability is associated with worse outcomes after cardiac surgery, but the prognosis value of early glycemic variability after transcatheter aortic valve implantation is not known. This study was therefore designed to analyze the prognosis significance of post-procedural glycemic variability within 30 days after transcatheter aortic valve implantation.
Source Cite
Published on Feb 25, 2019in Cardiovascular Diabetology 5.24
Lucia La Sala13
Estimated H-index: 13
,
Simona Mrakic-Sposta21
Estimated H-index: 21
(National Research Council)
+ 9 AuthorsGaia Spinetti26
Estimated H-index: 26
Background Impaired glucose tolerance (IGT) is a risk factor for the development of diabetes and related complications that ensue. Early identification of at-risk individuals might be beneficial to reduce or delay the progression of diabetes and its related complications. Recently, microRNAs emerged as potential biomarkers of diseases. The aim of the present study was to evaluate microRNA-21 as a potential biomarker for the risk of developing diabetes in adults with IGT and to investigate its do...
Source Cite
Published on Apr 15, 2019in Cardiovascular Diabetology 5.24
Xiaofeng Ye1
Estimated H-index: 1
(HUST: Huazhong University of Science and Technology),
Wen Kong1
Estimated H-index: 1
(HUST: Huazhong University of Science and Technology)
+ 1 AuthorsLulu Chen16
Estimated H-index: 16
(HUST: Huazhong University of Science and Technology)
Objective The importance of triglycerides (TG) level as a risk factor for cardiovascular diseases (CVD) has been extensively investigated in the general population; however, their relationship in patients with type 2 diabetes mellitus (T2DM) is uncertain. We aimed to assess the association of TG with CVD in T2DM individuals.
Source Cite
Published on Feb 28, 2019in Cardiovascular Diabetology 5.24
Huan Liu (WHU: Wuhan University), Yongnan Lyu (WHU: Wuhan University)+ 4 AuthorsYan Li42
Estimated H-index: 42
(WHU: Wuhan University)
Background There is a mutual interaction between inflammation and endocrine disorders in the development of coronary artery disease (CAD). Growth differentiation factor-15 (GDF-15) is associated with CAD, and the effects of testosterone on CAD as reported in literature have been considered as anti-atherosclerotic. The present study aimed to examine the possible association between serum GDF-15 and testosterone in male CAD patients.
Source Cite
Published on Jan 28, 2019in Cardiovascular Diabetology 5.24
Zheng Qin1
Estimated H-index: 1
(Capital Medical University),
Kuo Zhou1
Estimated H-index: 1
(Capital Medical University)
+ 6 AuthorsYujie Zhou14
Estimated H-index: 14
(Capital Medical University)
Background Increasing evidence has suggested that the presence of remnant lipoproteins is a significant risk factor for atherosclerosis. Remnant lipoproteins are lipoproteins that are rich in triglycerides (TGs), and the main components include very-low-density lipoprotein (VLDL) in the fasting state. Diabetic patients often have hypertriglyceridemia with elevated levels of VLDL cholesterol but normal levels of low-density lipoprotein cholesterol (LDL-C). The aim of the present study was to eluc...
Source Cite
Published on Apr 8, 2019in Cardiovascular Diabetology 5.24
Daya Yang2
Estimated H-index: 2
(SYSU: Sun Yat-sen University),
Xin He4
Estimated H-index: 4
(SYSU: Sun Yat-sen University)
+ 7 AuthorsXinxue Liao12
Estimated H-index: 12
(SYSU: Sun Yat-sen University)
Background The cardiovascular (CV) safety in terms of heart failure among different classes of treatment remains largely unknown. We sought to assess the comparative effect of these agents on heart failure outcomes.
Source Cite
Published on Mar 11, 2019in Cardiovascular Diabetology 5.24
Kyoung Jin Kim1
Estimated H-index: 1
(KU: Korea University),
Jimi Choi (KU: Korea University)+ 10 AuthorsKyung Mook Choi46
Estimated H-index: 46
(KU: Korea University)
Background To determine the impact of dipeptidyl peptidase-4 inhibitor (DPP4i) on the risk of major cardiocerebrovascular and renal outcomes compared with sulfonylurea (SU) combined with metformin in patients with type 2 diabetes from a population-based cohort.
Source Cite
12345678910